A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor

Phase 1 Recruiting 15 enrolled Tianjin Medical University Cancer Institute and Hospital Beijing Geekgene Technology Co., LTD · collab

NaSingle-groupOpen-labelTreatment

Summary

This study is a Phase I, open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.

Timeline

Start: 2025-03-18
Primary completion: 2028-03-18
Completion: 2028-07-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GK01	Cell therapy	—	—

Indications

No indication recorded.